| 000 | 01623 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513185842.0 | ||
| 264 | 0 | _c19990924 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a0169-5002 | ||
| 024 | 7 |
_a10.1016/s0169-5002(99)00010-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBurmeister, B H | |
| 245 | 0 | 0 |
_aChemoradiation for inoperable non small cell lung cancer: a phase II study using a regimen with acceptable toxicity. _h[electronic resource] |
| 260 |
_bLung cancer (Amsterdam, Netherlands) _cMar 1999 |
||
| 300 |
_a233-40 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCombined Modality Therapy _xadverse effects |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aGogna, N K | |
| 700 | 1 | _aBryant, G P | |
| 700 | 1 | _aArmstrong, J | |
| 700 | 1 | _aKelly, W | |
| 700 | 1 | _aMackintosh, J | |
| 700 | 1 | _aWalpole, E | |
| 700 | 1 | _aMorton, K | |
| 773 | 0 |
_tLung cancer (Amsterdam, Netherlands) _gvol. 23 _gno. 3 _gp. 233-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0169-5002(99)00010-0 _zAvailable from publisher's website |
| 999 |
_c10371279 _d10371279 |
||